Pharmaceuticals - Tel Aviv-Yafo, Tel Aviv District, Israel
Mental-Heal is developing a novel oral antipsychotic drug, PGW-5, for the treatment of Schizophrenia and Bipolar disorder. PGW-5 is a multi-target agent which is potentially effective for the treatment of the Positive and Negative Symptoms of Schizophrenia as well as, for Cognitive Deficits and Mood Disorder.